ANVISA Receives Top Score for Good Regulatory Practices

ANVISA is rated 10 for good regulatory practices according to the OECD.

QR Group analyzes the impact of agency performance for companies seeking registration of health products in Brazil ANVISA was rated 10 in the OECD Index of Good Regulatory Practices, according to a report released in April 2024. The index, prepared by the Organization for Economic Cooperation and Development, measures the quality of standard-making processes in […]